Urokinase from human urine - ≥85%,Potency ≥50000IU/mg,specific activeiy 120000IU/mg, high purity , CAS No.9039-53-6

  • EnzymoPure™
  • ≥85%
  • Potency ≥50000IU/mg,specific activeiy 120000IU/mg
Item Number
U108373
Grouped product items
SKUSizeAvailabilityPrice Qty
U108373-10mg
10mg
In stock
$299.90
U108373-50mg
50mg
In stock
$999.90

Basic Description

Synonyms079X63S3DU | CAMBENDAZOLE [MART.] | Cambendazole 100 microg/mL in Acetonitrile | MFCD00864552 | QZWHWHNCPFEXLL-UHFFFAOYSA-N | Camdan (TN) | NOE [French] | Equiben | J-690273 | SMR003475014 | DTXSID0046852 | isopropyl N-(2-thiazol-4-yl-1H-benzimidazol-5-yl
Specifications & PurityEnzymoPure™, ≥85%, Potency ≥50000IU/mg,specific activeiy 120000IU/mg
Biochemical and Physiological MechanismsUrokinase expression and invasiveness suppression by urinary trypsin inhibitor acts through MEK/ERK/c-Jun-dependent signaling pathways
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeEnzymoPure™
Product Description

Physical form Lyophilized from 1 mL of 50 mM Tris-HCl, pH 7.4 with 100 mM NaCl, 0.1% PEG 6000, and 200 mM mannitol Physical properties High molecular weight form migrating at 54 kDa by SDS-PAGE under non-reducing conditions
Urokinase is a protease that cleaves plasminogen to form plasmin. It binds to cell surface receptors (uPAR) from which it regulates cell adhesion and migration during tissue remodeling and which also activate intracellular signaling pathways. Urokinase is composed of three domains: the amino terminal domain which is homologous to epidermal growth factor is attached through a central kringle domain to the protease domain in the carboxyl terminus.

Associated Targets(Human)

TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Luciferin 4-monooxygenase (66902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid488183221
IUPAC Name propan-2-yl N-[2-(1,3-thiazol-4-yl)-3H-benzimidazol-5-yl]carbamate
INCHI InChI=1S/C14H14N4O2S/c1-8(2)20-14(19)16-9-3-4-10-11(5-9)18-13(17-10)12-6-21-7-15-12/h3-8H,1-2H3,(H,16,19)(H,17,18)
InChi Key QZWHWHNCPFEXLL-UHFFFAOYSA-N
Canonical SMILES CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3
Isomeric SMILES CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3
WGK Germany 3
RTECS OB8900000
PubChem CID 33309

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

9 results found

Lot NumberCertificate TypeDateItem
G2404241Certificate of AnalysisJun 11, 2024 U108373
G2404252Certificate of AnalysisJun 11, 2024 U108373
C2428054Certificate of AnalysisApr 01, 2024 U108373
C2226230Certificate of AnalysisDec 22, 2023 U108373
C2226247Certificate of AnalysisDec 22, 2023 U108373
C23081291Certificate of AnalysisFeb 28, 2023 U108373
C23081293Certificate of AnalysisFeb 28, 2023 U108373
C23081299Certificate of AnalysisFeb 28, 2023 U108373
K2016052Certificate of AnalysisSep 14, 2022 U108373

Safety and Hazards(GHS)

Pictogram(s) GHS08
Signal Warning
Hazard Statements

H361:Suspected of damaging fertility or the unborn child

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P405:Store locked up.

P501:Dispose of contents/container to ...

P203:Obtain, read and follow all safety instructions before use.

P318:if exposed or concerned, get medical advice.

WGK Germany 3
RTECS OB8900000

Related Documents

Citations of This Product

1. Zhechang Chen, Caijie Yuan, Yaxin Ye, Bitao Lu, Enling Hu, Fei Lu, Kun Yu, Ruiqi Xie, Guangqian Lan.  (2024)  Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.  CARBOHYDRATE POLYMERS,  328  (121703).  [PMID:38220339] [10.1016/j.carbpol.2023.121703]
2. Song Jianwen, Kang Xiaoying, Wang Lu, Ding Dan, Kong Deling, Li Wen, Qi Ji.  (2023)  Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles.  Nature Communications,  14  (1): (1-19).  [PMID:37898604] [10.1038/s41467-023-42691-8]
3. Weiwei Zhang, Yuguo Deng, Jinhao Zhao, Tao Zhang, Xiang Zhang, Wenping Song, Lin Wang, Tianlong Li.  (2023)  Amoeba-Inspired Magnetic Venom Microrobots.  Small,  19  (23): (2207360).  [PMID:36869412] [10.1002/smll.202207360]
4. Mei Jian feng, Cai Shao fen, Yi Yu, Wang Xu dong, Ying Guo qing.  (2023)  Study of the fibrinolytic activity of serrapeptase and its in vitro thrombolytic effects.  Brazilian Journal of Pharmaceutical Sciences,  58  (e201004).  [PMID:] [10.1590/s2175-97902022e201004]
5. Songzhi Xie, Shang Li, Wenxiong Cao, Chuanfei Mo, Zhanlin Zhang, Kun Huang, Xiaohong Li.  (2022)  Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy.  ACS Applied Materials & Interfaces,  14  (33): (37553–37565).  [PMID:35948498] [10.1021/acsami.2c11213]
6. Dongya Wang, Qianqian Zhao, Jingcan Qin, Yuanyuan Guo, Chuan Zhang, Yuehua Li.  (2022)  Urokinase loaded black phosphorus nanosheets for sequential thrombolysis and reactive oxygen species scavenging in ischemic stroke treatment.  Biomaterials Science,  10  (16): (4656-4666).  [PMID:35801526] [10.1039/D2BM00746K]
7. Songzhi Xie, Chuanfei Mo, Wenxiong Cao, Shuang Xie, Shang Li, Zhanlin Zhang, Xiaohong Li.  (2022)  Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.  Acta Biomaterialia,  142  (49).  [PMID:35158079] [10.1016/j.actbio.2022.02.008]

References

1. Zhechang Chen, Caijie Yuan, Yaxin Ye, Bitao Lu, Enling Hu, Fei Lu, Kun Yu, Ruiqi Xie, Guangqian Lan.  (2024)  Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.  CARBOHYDRATE POLYMERS,  328  (121703).  [PMID:38220339] [10.1016/j.carbpol.2023.121703]
2. Song Jianwen, Kang Xiaoying, Wang Lu, Ding Dan, Kong Deling, Li Wen, Qi Ji.  (2023)  Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles.  Nature Communications,  14  (1): (1-19).  [PMID:37898604] [10.1038/s41467-023-42691-8]
3. Weiwei Zhang, Yuguo Deng, Jinhao Zhao, Tao Zhang, Xiang Zhang, Wenping Song, Lin Wang, Tianlong Li.  (2023)  Amoeba-Inspired Magnetic Venom Microrobots.  Small,  19  (23): (2207360).  [PMID:36869412] [10.1002/smll.202207360]
4. Mei Jian feng, Cai Shao fen, Yi Yu, Wang Xu dong, Ying Guo qing.  (2023)  Study of the fibrinolytic activity of serrapeptase and its in vitro thrombolytic effects.  Brazilian Journal of Pharmaceutical Sciences,  58  (e201004).  [PMID:] [10.1590/s2175-97902022e201004]
5. Songzhi Xie, Shang Li, Wenxiong Cao, Chuanfei Mo, Zhanlin Zhang, Kun Huang, Xiaohong Li.  (2022)  Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy.  ACS Applied Materials & Interfaces,  14  (33): (37553–37565).  [PMID:35948498] [10.1021/acsami.2c11213]
6. Dongya Wang, Qianqian Zhao, Jingcan Qin, Yuanyuan Guo, Chuan Zhang, Yuehua Li.  (2022)  Urokinase loaded black phosphorus nanosheets for sequential thrombolysis and reactive oxygen species scavenging in ischemic stroke treatment.  Biomaterials Science,  10  (16): (4656-4666).  [PMID:35801526] [10.1039/D2BM00746K]
7. Songzhi Xie, Chuanfei Mo, Wenxiong Cao, Shuang Xie, Shang Li, Zhanlin Zhang, Xiaohong Li.  (2022)  Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.  Acta Biomaterialia,  142  (49).  [PMID:35158079] [10.1016/j.actbio.2022.02.008]

Solution Calculators